Anika Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $3.1M | $-867.5K | $4.0M | $958.0K |
| FY2010 | $7.9M | $5.1M | $2.8M | $1.1M |
| FY2011 | $10.2M | $8.8M | $1.4M | $1.2M |
| FY2012 | $10.5M | $9.0M | $1.5M | $1.2M |
| FY2013 | $25.2M | $24.7M | $441.0K | $1.3M |
| FY2014 | $40.0M | $38.4M | $1.6M | $1.6M |
| FY2015 | $39.9M | $30.7M | $9.2M | $2.2M |
| FY2016 | $24.4M | $10.4M | $14.0M | $3.4M |
| FY2017 | $40.8M | $31.8M | $9.0M | $5.8M |
| FY2018 | $34.9M | $30.3M | $4.7M | $11.0M |
| FY2019 | $37.0M | $34.2M | $2.8M | $6.1M |
| FY2020 | $13.1M | $11.4M | $1.6M | $5.4M |
| FY2021 | $8.4M | $3.3M | $5.1M | $11.1M |
| FY2022 | $4.4M | $-3.1M | $7.5M | $14.3M |
| FY2023 | $-1.8M | $-7.2M | $5.4M | $15.2M |
| FY2024 | $5.4M | $-2.3M | $7.7M | $13.1M |
| FY2025 | $11.2M | $4.4M | $6.8M | $10.1M |